QT Imaging Posts Record Q4 Results and Revenue Growth

QT Imaging Holdings ( (QTI) ) has issued an announcement.

QT Imaging reported that for the fourth quarter and full year ended December 31, 2025, it shipped a record 40 Breast Acoustic CT scanners and generated $18.9 million in revenue, surpassing its outlook and marking 288% year-over-year growth, while narrowing adjusted EBITDA losses despite a wider GAAP net loss driven by non-cash financing-related charges. Operational milestones in 2025 included an AMA-approved CPT code effective in 2027, new U.S. FDA clearance for an updated scanner configuration, a Nasdaq Capital Market uplisting, strengthened liquidity via an October 2025 private placement, and strategic collaborations with Intelerad, Olea Medical, and a UAE distributor that together underpin its affirmed 2026 revenue guidance of about $39 million and reinforce its shift toward a scalable, cloud-based breast imaging platform.

The company also reported record fourth-quarter 2025 revenue of $8.3 million, 877% higher than a year earlier, driven largely by shipments to its U.S. distributor NXC Imaging, though gross margins declined due to higher contract manufacturing costs. Leadership additions, including a new Chief Commercial Officer and a breast cancer researcher as Medical Advisor, along with expanded awareness initiatives, are intended to accelerate clinical adoption and commercial scaling as QT Imaging prepares to monetize its QTI Cloud Platform and fulfill minimum-order commitments exceeding $24 million in the UAE over 2026–2028.

The most recent analyst rating on (QTI) stock is a Hold with a $6.50 price target. To see the full list of analyst forecasts on QT Imaging Holdings stock, see the QTI Stock Forecast page.

Spark’s Take on QTI Stock

According to Spark, TipRanks’ AI Analyst, QTI is a Neutral.

The score is held down primarily by very weak financial performance (persistent losses and cash burn with historically fragile equity), partially offset by a strong recent corporate update pointing to accelerating revenue, improved losses, and strengthened financing. Technicals are neutral and valuation remains unattractive due to negative earnings.

To see Spark’s full report on QTI stock, click here.

More about QT Imaging Holdings

QT Imaging Holdings, Inc. is a U.S.-based medical device company focused on transforming breast health management through its Breast Acoustic CT scanner, a radiation-free, compression-free 3D breast imaging system. The company is transitioning from a traditional hardware model toward a SaaS- and biomarker-driven medical imaging platform, supported by its QTI Cloud Platform and international distribution partnerships, including in the United Arab Emirates.

Average Trading Volume: 40,642

Technical Sentiment Signal: Buy

Current Market Cap: $78.2M

For an in-depth examination of QTI stock, go to TipRanks’ Overview page.